BOOTHWYN, PA — Pentec Health, Inc. has moved to tighten its grip on one of the most specialized corners of chronic pain treatment, acquiring Hartley Medical Center Pharmacy, a nationally known compounding pharmacy focused on sterile intrathecal medications used in implanted pump therapy.
The deal brings together two companies that operate on different sides of the same clinical workflow. Hartley compounds the highly specialized drugs that go into implanted pumps, while Pentec provides national pharmacy services, nursing support, revenue cycle management and market access for physicians and patients. The combination is designed to give doctors a single, integrated partner for medication preparation, clinical delivery and administrative support.
Hartley Medical will continue operating out of its 503A pharmacy in Long Beach, California, and its founder and owner, William Stuart, will remain with the business as general manager. For more than three decades, Hartley has worked with interventional pain physicians nationwide, building a reputation around precision, compliance and safety in one of the most demanding areas of sterile compounding.
The pharmacy focuses exclusively on intrathecal therapies, using advanced processes that exceed United States Pharmacopeia <797> standards and a specialized staff trained specifically for implanted pump medications. That narrow focus has made Hartley a go-to partner for physicians who depend on consistent, high-quality compounding for chronic pain and spasticity patients.
Pentec Chief Executive Officer Matthew Deans said the acquisition creates a more seamless care model by aligning outsourced pharmacy services with Pentec’s existing national platform. Pentec already supports implanted pump patients in the home, while Hartley serves physicians who manage pumps in the office setting. Together, they allow doctors to choose the most appropriate site of care without sacrificing access to medication, nursing or administrative infrastructure.
The combined company aims to reduce the operational burden on physician practices by bringing pharmacy services, nursing care and back-office support under one roof. That model is increasingly attractive as practices face tighter reimbursement, higher compliance costs and growing demand for complex therapies delivered outside of hospitals.
Stuart said Hartley’s reputation is built on trust and technical excellence in sterile intrathecal compounding, and that joining Pentec allows the pharmacy to preserve its identity while gaining a broader support system around it. He said the move will expand Hartley’s ability to serve physicians and patients without compromising the standards that made it successful.
For Pentec, the acquisition strengthens its position in a niche but fast-evolving segment of specialty pharmacy and home-based care. By vertically integrating medication preparation with clinical and administrative services, the company is betting that a more coordinated approach will improve outcomes, lower friction for providers and create a more scalable platform for implanted pump therapy.
As health care continues to shift toward specialized, site-flexible treatment models, Pentec’s move signals a push to own more of the care pathway in chronic pain management, from the pharmacy clean room to the patient’s bedside.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.